Literature DB >> 12031862

Additional evidence for the involvement of the basal ganglia in formalin-induced nociception: the role of the nucleus accumbens.

Jane E Magnusson1, Roxanne V Martin.   

Abstract

Identification of the brain areas that contribute to pain is an essential undertaking towards understanding persistent pain. Areas of the basal ganglia have been proposed to play important roles in nociception as previous studies have determined the involvement of the substantia nigra pars compacta and the dorsolateral striatum in pain. The purpose of the present study was therefore to expand upon these findings by determining the involvement of other areas of the basal ganglia such as the nucleus accumbens shell and core in formalin-induced nociception. It was found that injection of a local anaesthetic (bupivacaine) into the nucleus accumbens shell had no effect on formalin-induced nociception. However, injection into the nucleus accumbens core enhanced formalin-induced nociception. These results implicate the nucleus accumbens in the processing of pain and provide additional evidence for the involvement of the basal ganglia and possibly dopamine in pain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031862     DOI: 10.1016/s0006-8993(02)02489-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Analogous responses in the nucleus accumbens and cingulate cortex to pain onset (aversion) and offset (relief) in rats and humans.

Authors:  L Becerra; E Navratilova; F Porreca; D Borsook
Journal:  J Neurophysiol       Date:  2013-06-19       Impact factor: 2.714

2.  Activation of corticostriatal circuitry relieves chronic neuropathic pain.

Authors:  Michelle Lee; Toby R Manders; Sarah E Eberle; Chen Su; James D'amour; Runtao Yang; Hau Yueh Lin; Karl Deisseroth; Robert C Froemke; Jing Wang
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

3.  Persistent neuropathic pain increases synaptic GluA1 subunit levels in core and shell subregions of the nucleus accumbens.

Authors:  Duo Xu; Chen Su; Hau-Yueh Lin; Toby Manders; Jing Wang
Journal:  Neurosci Lett       Date:  2015-10-22       Impact factor: 3.046

4.  Top-Down Cortical Control of Acute and Chronic Pain.

Authors:  Louise Urien; Jing Wang
Journal:  Psychosom Med       Date:  2019 Nov/Dec       Impact factor: 4.312

5.  Attenuated dopamine receptor signaling in nucleus accumbens core in a rat model of chemically-induced neuropathy.

Authors:  Dana E Selley; Matthew F Lazenka; Laura J Sim-Selley; Julie R Secor McVoy; David N Potter; Elena H Chartoff; William A Carlezon; S Stevens Negus
Journal:  Neuropharmacology       Date:  2020-01-07       Impact factor: 5.250

6.  Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state.

Authors:  Yossef Goffer; Duo Xu; Sarah E Eberle; James D'amour; Michelle Lee; David Tukey; Robert C Froemke; Edward B Ziff; Jing Wang
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

7.  AMPAkines Target the Nucleus Accumbens to Relieve Postoperative Pain.

Authors:  Chen Su; Hau Yeuh Lin; Runtao Yang; Duo Xu; Michelle Lee; Natalie Pawlak; Monica Norcini; Alexandra Sideris; Esperanza Recio-Pinto; Dong Huang; Jing Wang
Journal:  Anesthesiology       Date:  2016-11       Impact factor: 7.892

8.  Corticostriatal Regulation of Acute Pain.

Authors:  Erik Martinez; Harvey H Lin; Haocheng Zhou; Jahrane Dale; Kevin Liu; Jing Wang
Journal:  Front Cell Neurosci       Date:  2017-05-26       Impact factor: 5.505

9.  Inhibition of the Prefrontal Projection to the Nucleus Accumbens Enhances Pain Sensitivity and Affect.

Authors:  Haocheng Zhou; Erik Martinez; Harvey H Lin; Runtao Yang; Jahrane Antonio Dale; Kevin Liu; Dong Huang; Jing Wang
Journal:  Front Cell Neurosci       Date:  2018-08-13       Impact factor: 6.147

10.  AMPAkines potentiate the corticostriatal pathway to reduce acute and chronic pain.

Authors:  Fei Zeng; Qiaosheng Zhang; Yaling Liu; Guanghao Sun; Anna Li; Robert S Talay; Jing Wang
Journal:  Mol Brain       Date:  2021-03-02       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.